Specifically, TRPA1 has been detected in CD4+ T cells infiltrating the colonic tissue samples of both UC and CD patients, where its stimulation controls CD4+ T-cell activation and proinflammatory responses, thus suggesting an important contribution of the channel in the pathogenesis of IBD [121]. Here, CD4 is linked to inflammatory bowel disease.